Ketchum John B - Insider Non-Derivative Transactions at Tango Therapeutics, Inc. (TNGX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 5, 2024, Ketchum John B's relationship to Tango Therapeutics, Inc. (TNGX) is Director, and currently has 14,687 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other TNGX insiders.

Data Source: SEC.
Ketchum John B - Insider Non-Derivative Transactions of TNGX Common Stock
Oct 01Jan 01Apr 0102K4K6K8K10K12K14K16K
Ketchum John B - Insider Non-Derivative Transactions at TNGX
Date
Transaction
No. of Shares
Price Per Share
Shares Owned After Transactions
Jun 6, 2024 Acquisition -- (Common Stock) 4,687 0 14,687
Aug 30, 2023 Acquisition -- (Common Stock) 10,000 0 10,000
Items per page:
1 – 2 of 2